1. 122TiPGeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo. (13th May 2019) Authors: Loibl, S; Jackisch, C; Rastogi, P; Seiler, S; Lucas, P C; Denkert, C; Costantino, J; Nekljudova, V; Wolmark, N; Geyer, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Issue 10 (1st April 2023) Authors: Fisher, B; Bryant, J; Wolmark, N; Mamounas, E; Brown, A; Fisher, E R; Wickerham, D L; Begovic, M; DeCillis, A; Robidoux, A; Margolese, R G; Cruz, A B; Hoehn, J L; Lees, A W; Dimitrov, N V; Bear, H D Journal: Journal of clinical oncology Issue: Volume 41:Issue 10(2023) Page Start: 1795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA4Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: An update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC). (24th November 2019) Authors: Untch, M; Geyer, C E; Huang, C; Loibl, S; Wolmark, N; Mano, M S; von Minckwitz, G; Brufsky, A; Pivot, X; Polikoff, J; Fontana, A; Kaufman, B; Alcedo, J C; Boulet, T; Liu, H; Song, C; Mamounas, E P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗